← Open Payments lookup

AMBER LAMUS: Open Payments

NPI 1184084568 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$553 in 46 payments from 6 companies in 2025. Trend: 2023 $315 · 2024 $213 · 2025 $553

Food & beverage: $553
CompanyPaymentsAmount
ABBVIE INC.29$229
Otsuka America Pharmaceutical, Inc.5$104
Neurocrine BioSciences, Inc.5$91
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$68
Janssen Pharmaceuticals, Inc2$30
Teva Pharmaceuticals USA, Inc.2$30

Products named: VRAYLAR, INGREZZA, ABILIFY MAINTENA, CAPLYTA, REXULTI, INVEGA SUSTENNA, UZEDY.

Industry payments across OH — which companies pay providers there.